Joseph Roland
Managing Director
Last active: 10/5/2017

  1. Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity. McKinley ET, Sui Y, Al-Kofahi Y, Millis BA, Tyska MJ, Roland JT, Santamaria-Pang A, Ohland CL, Jobin C, Franklin JL, Lau KS, Gerdes MJ, Coffey RJ (2017) JCI Insight 2(11)
    › Primary publication · 28570279 (PubMed) · PMC5453701 (PubMed Central)
  2. Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis. Jeong S, Choi E, Petersen CP, Roland JT, Federico A, Ippolito R, D'Armiento FP, Nardone G, Nagano O, Saya H, Romano M, Goldenring JR (2017) United European Gastroenterol J 5(1): 37-44
    › Primary publication · 28405320 (PubMed) · PMC5384548 (PubMed Central)
  3. Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease. Vogel GF, Janecke AR, Krainer IM, Gutleben K, Witting B, Mitton SG, Mansour S, Ballauff A, Roland JT, Engevik AC, Cutz E, Müller T, Goldenring JR, Huber LA, Hess MW (2017) Traffic 18(7): 453-464
    › Primary publication · 28407399 (PubMed) · PMC5693299 (PubMed Central)
  4. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma:  A Comparison With AMACR. Goldstein J, Goyal R, Roland JT, Gellert LL, Clark PE, Hameed O, Giannico GA (2016) Am J Clin Pathol 146(3): 294-302
    › Primary publication · 27543977 (PubMed)
  5. MAGI-2 in prostate cancer: an immunohistochemical study. Goldstein J, Borowsky AD, Goyal R, Roland JT, Arnold SA, Gellert LL, Clark PE, Hameed O, Giannico GA (2016) Hum Pathol : 83-91
    › Primary publication · 26980016 (PubMed)
  6. Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus. Harlow ML, Maloney N, Roland J, Guillen Navarro MJ, Easton MK, Kitchen-Goosen SM, Boguslawski EA, Madaj ZB, Johnson BK, Bowman MJ, D'Incalci M, Winn ME, Turner L, Hostetter G, Galmarini CM, Aviles PM, Grohar PJ (2016) Cancer Res 76(22): 6657-6668
    › Primary publication · 27697767 (PubMed) · PMC5567825 (PubMed Central)
  7. Loss of MYO5B in mice recapitulates Microvillus Inclusion Disease and reveals an apical trafficking pathway distinct to neonatal duodenum. Weis VG, Knowles BC, Choi E, Goldstein AE, Williams JA, Manning EH, Roland JT, Lapierre LA, Goldenring JR (2016) Cell Mol Gastroenterol Hepatol 2(2): 131-157
    › Primary publication · 27019864 (PubMed) · PMC4806369 (PubMed Central)
  8. Rab11a regulates syntaxin 3 localization and microvillus assembly in enterocytes. Knowles BC, Weis VG, Yu S, Roland JT, Williams JA, Alvarado GS, Lapierre LA, Shub MD, Gao N, Goldenring JR (2015) J Cell Sci 128(8): 1617-26
    › Primary publication · 25673875 (PubMed) · PMC4518445 (PubMed Central)
  9. Rab11-FIP2 interaction with MYO5B regulates movement of Rab11a-containing recycling vesicles. Schafer JC, Baetz NW, Lapierre LA, McRae RE, Roland JT, Goldenring JR (2014) Traffic 15(3): 292-308
    › Primary publication · 24372966 (PubMed) · PMC4081500 (PubMed Central)
  10. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. Knowles BC, Roland JT, Krishnan M, Tyska MJ, Lapierre LA, Dickman PS, Goldenring JR, Shub MD (2014) J Clin Invest 124(7): 2947-62
    › Primary publication · 24892806 (PubMed) · PMC4071383 (PubMed Central)